Author:
Furtado Ruelan,Crawford Michael,Sandroussi Charbel
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. McGlynn KA, London WT. The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis. 2011;15(2):223–43, vii–x.
2. Abrams P, Marsh JW. Current approach to hepatocellular carcinoma. Surg Clin N Am. 2010;90(4):803–16.
3. Chou FI, Fang KC, Chung C, et al. Lipiodol uptake and retention by human hepatoma cells. Nucl Med Biol. 1995;22(3):379–86.
4. Rindani RB, Hugh TJ, Roche J, Roach PJ, Smith RC. 131I lipiodol therapy for unresectable hepatocellular carcinoma. ANZ J Surg. 2002;72(3):210–4.
5. Raoul JL, Guyader D, Bretagne JF, et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med. 1994;35(11):1782–7.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献